Want to see TSHA full AI Analyst Report?
Taysha Gene Therapies (TSHA) Income Statement
1,290 Followers
Taysha Gene Therapies Income Statement
Last quarter (Q2 2026), Taysha Gene Therapies's total revenue was $0.00, a decrease of 100.00% from the same quarter last year. In Q2, Taysha Gene Therapies's net income was $-46.64M. See Taysha Gene Therapies’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 9.77M | $ 8.33M | $ 15.45M | $ 2.50M | $ 0.00 | |
| $ 9.77M | $ 8.33M | $ 15.45M | $ 15.00K | $ 0.00 | |
| $ 120.27M | $ 99.79M | $ 87.89M | $ 126.04M | $ 173.27M | |
| Depreciation and Amortization | $ 1.15M | $ 1.25M | $ 1.37M | $ 1.17M | $ 492.00K |
| $ -107.79M | $ -87.95M | $ -105.20M | $ -161.04M | $ -172.60M | |
| $ -110.50M | $ -91.46M | $ -72.44M | $ -126.03M | $ -173.27M | |
| $ 1.50M | $ 2.16M | $ -39.13M | $ -39.99M | $ -1.26M | |
| $ -109.00M | $ -89.30M | $ -111.57M | $ -166.01M | $ -174.52M | |
| $ -109.00M | $ -89.30M | $ -111.57M | $ -166.01M | $ -174.52M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.34 | $ -0.36 | $ -0.96 | $ -3.78 | $ -4.64 |
| Diluted EPS | $ -0.34 | $ -0.36 | $ -0.96 | $ -3.78 | $ -4.64 |
| Weighted Average Shares Outstanding | 319.71M | 250.13M | 116.12M | 43.95M | 37.65M |
| Weighted Average Shares Outstanding (Diluted) | 319.71M | 250.13M | 116.12M | 43.95M | 37.65M |
Currency in USD
